-+ 0.00%
-+ 0.00%
-+ 0.00%
Microsoft's Amini Says AI Could Cut Drug Discovery Costs by Targeting Lab Experiments
Share
Listen to the news
Microsoft's Amini Says AI Could Cut Drug Discovery Costs by Targeting Lab Experiments
  • Microsoft's Eric Horvitz highlighted AI research targeting more accurate, cost-conscious diagnoses through sequential testing to support clinicians.
  • Eric Topol said the diagnostic system nearly doubled physicians' accuracy at lower cost in the study.
  • Ava Amini identified implementation as a key challenge, citing collaboration with the Broad Institute to integrate AI into biological research.
  • Amini said virtual experiments could reduce discovery costs and timelines by focusing laboratory resources on the most promising research.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microsoft Corporation published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending